Gold is above $4,500 per ounce and Agnico Eagle (AEM) holds one of the strongest fundamental profiles in the Stoxcraft universe. The business quality is real. What is not matching up is the short-term trend, which is flashing the platform's most bearish signal while the fundamentals sit at their peak.
AEM's score profile right now
Agnico Eagle ranks in the top 5% of all 3,884 stocks on Stoxcraft. That exceptional fundamental reading and the crashing short-term trend are the two signals creating the contradiction right now.
What drives AEM's Health Score of 9.2/10
The score is anchored by extraordinary free cash flow generation, producing $8.76 per share in 2025. All-in sustaining costs of $1,339/oz sit far below gold at $4,500+. Net cash exceeds $2B. Fitch upgraded the credit rating to A- in April 2026. These metrics place AEM above Barrick Gold (GOLD) and Newmont (NEM) on every key measure the platform tracks in this sector.
What the Crashing trend signal reveals about AEM's short-term pressure
The MACD is negative. RSI has dropped sharply. AEM fell roughly 15% in one month while gold fell only 4%. That divergence pushed the trend signal to ▼▼▼ Crashing, the most bearish of six levels on Stoxcraft. The drawdown from the 52-week high now exceeds what the commodity price move alone would justify.
What the market currently thinks about AEM
The bullish case has not broken. AEM's 2025 free cash flow hit a record $4.4B, doubling year-over-year. Q1 2026 added record operating margins and net income of $1.695B. 22 analysts maintain a Buy rating with a consensus price target implying nearly 59% upside. The fundamental narrative is intact. The short-term price behavior is not following it.
Where the Stoxcraft scores diverge on AEM
Both the Health Score and the trend signal are accurate. They measure different things. That is the tension at the center of this stock right now.
What the Health Score captures that the trend signal ignores
Free cash flow per share outranks nearly every gold mining peer on the platform. The Performance Score of 8.0/10 reflects genuine multi-year outperformance versus the S&P 500. The operating business is at a historically high level of performance.
What the technical breakdown captures that the Health Score cannot
Every short-term indicator is aligned bearish. The Risk Score of 6.4/10 signals elevated volatility, high for a company with this quality of fundamentals, driven by short-term price momentum deteriorating faster than the business has.
The Value Trap Warning pattern in AEM
This is a textbook Value Trap Warning archetype: a top-tier Health Score alongside a collapsing short-term trend. The entry signal is Buy, but it is driven by analyst conviction rather than improving technical conditions. For this archetype to resolve into a genuine opportunity, the trend signal needs to stabilize first.
A second anomaly worth watching: Newmont (NEM)
Newmont (NEM) sits in the middle of its peer group on fundamentals, solid within materials but far from AEM's top-5% tier. The anomaly here is distinct: NEM has dramatically underperformed the gold price rally relative to what its profile would suggest.
J.P. Morgan projects gold approaching $5,000/oz by Q4 2026, with central bank demand at 585 tonnes per quarter. Gold at those levels should lift senior producers broadly. Yet NEM continues to trade at a meaningful discount to its own historical valuation multiples. The trend signal has not recovered at the pace the commodity price would imply. Analysts remain divided rather than aligned. If momentum turns and that discount begins to compress, NEM could offer a contrarian setup worth tracking. The fundamental quality is lower than AEM, but the potential price gap to close is wider if conditions align.
Whether AEM's trend catches up to its fundamentals in H2 2026
AEM's production is weighted toward the second half of 2026. A strong Q2 or Q3 result, with free cash flow accelerating further under gold prices above $4,500, could give the market a reason to close the gap between a 9.2 Health Score and a stock behaving like a weaker name.
Watch whether MACD turns positive. Watch whether RSI stabilizes above oversold territory. That is when the Value Trap Warning has a chance to resolve.